Chord Energy Q1 GAAP EPS Down 51% to $1.90 Amid $241.5M Derivative Loss; Key Executives Adopt Selling Plans
summarizeSummary
Chord Energy reported Q1 GAAP diluted EPS of $1.90, a 51% decrease year-over-year, primarily due to a $241.5 million net loss on derivative instruments. This filing also disclosed new Rule 10b5-1 selling plans adopted by the CEO and an EVP.
check_boxKey Events
-
Q1 GAAP Earnings Decline
Diluted EPS of $1.90 for Q1 2026, a 51% decrease from $3.66 in Q1 2025, contrasting with a previously reported adjusted EPS beat.
-
Major Derivative Losses Impact Net Income
A net loss of $241.5 million on derivative instruments in Q1 2026, primarily from unrealized losses due to an upward shift in the crude oil futures curve, significantly impacted net income.
-
Reduced Operating Cash Flow
Net cash provided by operating activities decreased by 23% year-over-year to $507.5 million.
-
Executive Selling Plans Adopted
CEO Daniel E. Brown and EVP Michael H. Lou adopted Rule 10b5-1 trading arrangements on March 16, 2026, to sell a combined 90,000 shares, valued at approximately $12.42 million.
auto_awesomeAnalysis
Chord Energy's Q1 2026 GAAP results reveal a significant 51% year-over-year decline in diluted EPS to $1.90, contrasting with a previously reported adjusted EPS beat. This substantial drop is primarily attributed to a $241.5 million net loss on derivative instruments, largely unrealized due to an upward shift in the crude oil futures curve. While total revenues increased, operating cash flow decreased, and share repurchases were significantly lower than the prior year. Additionally, the filing disclosed new Rule 10b5-1 selling plans adopted by the CEO and an Executive Vice President, signaling potential insider distribution. Investors should note the divergence between adjusted and GAAP earnings and the impact of hedging strategies in a volatile commodity market.
At the time of this filing, CHRD was trading at $138.00 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $84.25 to $150.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.